Question 1

How many shares of VKTX does UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC own?

Accepted Answer

As of 2026-Q2, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 229,973 shares of VKTX (VIKING THERAPEUTICS INC).

Question 2

What is UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's VKTX position worth?

Accepted Answer

As of 2026-Q2, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's VKTX position is worth $9M.

Question 3

Is UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC buying or selling VKTX?

Accepted Answer

In 2026-Q2, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC decreased their VKTX position (-9.4% change in shares).

Question 4

When did UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC first buy VKTX?

Accepted Answer

Based on available 13F filings, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC first reported a position in VKTX in 2024-Q3. They have held the position across 27 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	229,973	-9.4%	$9M	0.0%	$39.01	0
2026-Q1	Increased	253,894	+6.6%	$8.3M	0.0%	$31.93	29
2025-Q4	Decreased	238,227	-2.3%	$8.4M	0.0%	$35.32	0
2025-Q3	Decreased	243,766	-52.1%	$6.4M	0.0%	$25.81	0
2025-Q2	Increased	509,094	+8.3%	$13.5M	0.0%	$26.52	30
2025-Q1	Increased	470,028	+1.4%	$11.4M	0.0%	$25.65	28
2024-Q4	Decreased	463,332	-1.9%	$18.6M	0.0%	$39.77	0
2024-Q3	Decreased	472,244	-1.5%	$29.9M	0.0%	$61.63	0